Suppr超能文献

测量球囊在卵圆孔未闭封堵器尺寸选择中的作用。

The role of the sizing balloon in selection of the patent foramen ovale closure device size.

作者信息

Alibegovic J, Bonvini Rf, Sigwart U, Dorsaz Pa, Camenzind E, Verin V

机构信息

Division of Cardiology, University Hospital of Geneva, Geneva, Switzerland.

出版信息

Exp Clin Cardiol. 2008 Spring;13(1):42-6.

Abstract

OBJECTIVES

To find a correlation between the patent foramen ovale (PFO) size measured by the sizing balloon and the appropriate closure device size.

METHODS

The PFO of 57 patients was closed using a sizing balloon. A mathematical model was introduced to relate the PFO balloon waist diameter to the closure device size based on the PFO transformation from a slit-like to a circular form during balloon inflation. According to this model, PFOs smaller than 8 mm should be closed with a 25 mm device, PFOs 8 mm to 11 mm with a 35 mm device, and PFOs larger than 11 mm with an Amplatzer septal occluder. In the first group, 36 patients (63.2%) received an appropriately sized device and six patients (10.5%) received an oversized device. In the second group, 15 patients (26.3%) received an undersized device.

RESULTS

A comparison of the PFO dimensions in two views showed that the PFO slit was circular when the balloon was inflated. A six-month echocardiography follow-up was obtained in 46 patients (80.7%). Five patients (13.9%) in the group with an appropriately sized device had a discrete residual shunt during Valsalva. In the second group, five patients (33.3%) had a residual shunt (P = 0.06), of which one was considered large.

CONCLUSION

The sizing balloon is helpful in selecting the PFO closure device size. Consequently, the incidence of residual shunt and recurrent events may be reduced.

摘要

目的

探寻通过测量球囊大小得出的卵圆孔未闭(PFO)大小与合适的封堵装置大小之间的相关性。

方法

使用测量球囊对57例患者的PFO进行封堵。引入一个数学模型,基于球囊充盈过程中PFO从缝隙状转变为圆形的情况,将PFO球囊腰部直径与封堵装置大小相关联。根据该模型,小于8mm的PFO应用25mm的装置封堵,8mm至11mm的PFO应用35mm的装置封堵,大于11mm的PFO应用Amplatzer房间隔封堵器封堵。在第一组中,36例患者(63.2%)接受了尺寸合适的装置,6例患者(10.5%)接受了尺寸过大的装置。在第二组中,15例患者(26.3%)接受了尺寸过小的装置。

结果

两个视图中PFO尺寸的比较显示,球囊充盈时PFO缝隙呈圆形。46例患者(80.7%)获得了为期6个月的超声心动图随访。尺寸合适装置组中有5例患者(13.9%)在瓦尔萨尔瓦动作时存在微量残余分流。在第二组中,5例患者(33.3%)存在残余分流(P = 0.06),其中1例被认为分流较大。

结论

测量球囊有助于选择PFO封堵装置的大小。因此,可能会降低残余分流和复发事件的发生率。

相似文献

3
Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Catheter Cardiovasc Interv. 2014 Sep 1;84(3):455-63. doi: 10.1002/ccd.25453. Epub 2014 Mar 4.
4
A comparison of methods to determine patent foramen ovale size.
Catheter Cardiovasc Interv. 2020 Nov;96(6):E621-E629. doi: 10.1002/ccd.28665. Epub 2019 Dec 24.
5
Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):349-354. doi: 10.1002/ccd.28360. Epub 2019 May 27.
7
Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
EuroIntervention. 2017 Sep 20;13(7):858-866. doi: 10.4244/EIJ-D-17-00061.
8
Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
Clin Res Cardiol. 2008 Dec;97(12):872-7. doi: 10.1007/s00392-008-0699-9. Epub 2008 Aug 11.
9
Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
J Interv Cardiol. 2010 Dec;23(6):575-80. doi: 10.1111/j.1540-8183.2010.00587.x. Epub 2010 Aug 27.
10
Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):365-372. doi: 10.1002/ccd.28527. Epub 2019 Oct 26.

引用本文的文献

1
Treatment of patent foramen ovale.
EuroIntervention. 2025 May 16;21(10):505-524. doi: 10.4244/EIJ-D-23-00915.
2
A Glimpse Beyond Typical Dyspnea.
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101200. doi: 10.1016/j.jscai.2023.101200. eCollection 2023 Nov-Dec.
5
A Practical Scoring System to Select Optimally Sized Devices for Percutaneous Patent Foramen Ovale Closure.
J Struct Heart Dis. 2016 Oct;2(5):217-223. doi: 10.12945/j.jshd.2016.009.15.
6
Potential Role of Patent Foramen Ovale in Exacerbating Hypoxemia in Chronic Pulmonary Disease.
Tex Heart Inst J. 2017 Jun 1;44(3):189-197. doi: 10.14503/THIJ-16-6027. eCollection 2017 Jun.
7
Platypnea-Orthodeoxia Syndrome: Diagnostic Challenge and the Importance of Heightened Clinical Suspicion.
Tex Heart Inst J. 2015 Oct 1;42(5):498-501. doi: 10.14503/THIJ-14-4596. eCollection 2015 Oct.

本文引用的文献

2
Patent foramen ovale: current pathology, pathophysiology, and clinical status.
J Am Coll Cardiol. 2005 Nov 1;46(9):1768-76. doi: 10.1016/j.jacc.2005.08.038. Epub 2005 Sep 29.
4
Closure of patent foramen ovale: technique, pitfalls, complications, and follow up.
Heart. 2005 Apr;91(4):444-8. doi: 10.1136/hrt.2004.052258.
6
Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
Catheter Cardiovasc Interv. 2004 Aug;62(4):519-25. doi: 10.1002/ccd.20121.
8
Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices.
Am J Cardiol. 2004 Feb 15;93(4):426-31. doi: 10.1016/j.amjcard.2003.10.036.
10
Morphological features pertinent to interventional closure of patent oval foramen.
J Interv Cardiol. 2003 Feb;16(1):33-8. doi: 10.1046/j.1540-8183.2003.08000.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验